Steve Pakola insider trades

Open-market stock purchases and sales by Steve Pakola, Chief Medical Officer at REGENXBIO Inc, from SEC Form 4 filings since Apr 23, 2018.

Recent trades

DateStockTradeValue
Aug 1, 2026RGNX REGENXBIO IncSold (not open market)$72.4K
Jul 2, 2026RGNX REGENXBIO IncBought (not open market)—
Jul 2, 2026RGNX REGENXBIO IncSold$29.5K
May 11, 2026RGNX REGENXBIO IncSold$169K
Mar 10, 2026RGNX REGENXBIO IncSold$53K
Feb 1, 2026RGNX REGENXBIO IncSold (not open market)$58.8K
Jan 6, 2026RGNX REGENXBIO IncBought (not open market)—
Jan 6, 2026RGNX REGENXBIO IncBought (not open market)—
Jan 2, 2026RGNX REGENXBIO IncSold (not open market)$263K

Companies traded

  • RGNX REGENXBIO Inc: 7 sales, last Aug 1, 2026
  • ARPO Aerpio Pharmaceuticals, Inc: other filings, last Feb 15, 2019

Get free alerts when Steve Pakola files a new trade →